Inhibikase Therapeutics, Inc. (IKT)
1.80
+0.04
(+2.27%)
USD |
NASDAQ |
Feb 23, 16:00
1.83
+0.03
(+1.67%)
After-Hours: 19:59
Inhibikase Therapeutics Total Liabilities (Quarterly) : 6.696M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Beta Bionics, Inc. | 39.59M |
| ACADIA Pharmaceuticals, Inc. | 413.50M |
| Agenus, Inc. | 514.76M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
| Savara, Inc. | 46.54M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 79.59M |
| Shareholders Equity (Quarterly) | 72.90M |
| Current Ratio | 11.67 |
| Net Debt Paydown Yield | 0.03% |